Otezla
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
55513-137 -
Package NDC
55513-137-60 -
Package NDC
55513-137-95 -
Application number
NDA205437 -
SPL ID
8d1d49ca-6dc1-4580-b2d5-f69ccb4f1c8e -
SPL set ID
f6b1f516-4972-4d82-bced-113e47b41cc5 -
UNII
UP7QBP99PN -
RxCUI
1492732 -
RxCUI
1492738 -
RxCUI
1492740 -
RxCUI
1492742 -
RxCUI
1492744 -
RxCUI
1492746 -
RxCUI
1492747 -
RxCUI
1492748 -
RxCUI
1605454 -
RxCUI
1605455 -
RxCUI
2682429 -
RxCUI
2682430 -
RxCUI
2682431 -
RxCUI
2682432 -
RxCUI
2723448 -
RxCUI
2723452 -
RxCUI
2724366 -
RxCUI
2724367
What the source publishes
- Labeler
- Amgen, Inc
- Active ingredients
- apremilast
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Otezla",
"splId": "8d1d49ca-6dc1-4580-b2d5-f69ccb4f1c8e",
"labels": [
{
"setId": "f6b1f516-4972-4d82-bced-113e47b41cc5",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6b1f516-4972-4d82-bced-113e47b41cc5",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f6b1f516-4972-4d82-bced-113e47b41cc5"
}
],
"routes": [
"ORAL"
],
"labeler": "Amgen, Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 TABLET, FILM COATED in 1 BOTTLE (55513-137-60)",
"package_ndc": "55513-137-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20200226"
},
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (55513-137-95) / 28 TABLET, FILM COATED in 1 BLISTER PACK",
"package_ndc": "55513-137-95",
"identifierStatus": "well-formed",
"marketing_start_date": "20200226"
}
],
"productId": "55513-137_8d1d49ca-6dc1-4580-b2d5-f69ccb4f1c8e",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "55513-137",
"deaSchedule": null,
"genericName": "apremilast",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "APREMILAST",
"strength": "30 mg/1"
}
],
"applicationNumber": "NDA205437",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200226",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000182961",
"N0000182960"
],
"upc": [
"0355513137607"
],
"unii": [
"UP7QBP99PN"
],
"rxcui": [
"1492732",
"1492738",
"1492740",
"1492742",
"1492744",
"1492746",
"1492747",
"1492748",
"1605454",
"1605455",
"2682429",
"2682430",
"2682431",
"2682432",
"2723448",
"2723452",
"2724366",
"2724367"
],
"spl_set_id": [
"f6b1f516-4972-4d82-bced-113e47b41cc5"
],
"pharm_class_epc": [
"Phosphodiesterase 4 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Phosphodiesterase 4 Inhibitors [MoA]"
],
"manufacturer_name": [
"Amgen, Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:55513-137_8d1d49ca-6dc1-4580-b2d5-f69ccb4f1c8e"